Multiple Sclerosis (MS) is a chronic autoimmune disorder for which there is currently no cure. Management of MS during the COVID-19 pandemic created challenges for patients in the Kingdom and around the World. In this webinar, our panel of international experts will review the current COVID-19 protection and vaccine recommendations for patients with MS and NMOSD. Panelists will also discuss the updates on treatment management and new evidence with MS and NMOSD disease modifying therapies and how this will influence practice today and in the near future.
This activity is supported by an independent educational grant from Roche Products Saudi Arabia.